Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tiziana Life Sciences Ltd (NQ: TLSA ) 1.080 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Tiziana Life Sciences Ltd < Previous 1 2 3 4 5 6 7 8 Next > 3 EV Stocks to Buy for the Next Bull Run: March 2024 March 28, 2024 EV stocks have broadly underperformed the market in 2024, which has, in turn, created a number of opportunities to buy at a bargain. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 05, 2024 Via Benzinga Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease March 05, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire 7 Over-Hyped Stocks to Sell Before They Plunge January 25, 2024 It wasn't too long ago that these stocks were considered hot commodities. But now they're just overhyped stocks to sell. Via InvestorPlace Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients January 08, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024 January 05, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation January 05, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis December 19, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says December 13, 2023 Tesla shares fell only slightly. And auto recalls are nothing new. Recall how, in 1981, Ford issued a recall on 21 million vehicles. Via Benzinga Topics Product Recall Exposures Legal Product Safety Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024 December 12, 2023 After a volatile 2023, equity markets appear to be rallying into 2024. Can they keep it up? Via Benzinga Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar December 04, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Expects To Start Enrolling Patients in Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using its Novel Intranasal Monoclonal Antibody Foralumab December 01, 2023 --News Direct-- Via News Direct Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab November 30, 2023 This month, Tiziana Life Sciences (NASDAQ: TLSA) expects to start enrolling patients for a phase 2a trial of Foralumab, an immunomodulation therapy for Secondary Progressive Multiple Sclerosis (SPMS)... Via Benzinga Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis November 30, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire SPDR ETF Report For Tuesday, November 21 November 22, 2023 Via Talk Markets Topics ETFs Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023 November 01, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday October 19, 2023 We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session October 18, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 18, 2023 Pre-market stock movers are a hot topic worth checking out on Wednesday and we have all the latest news happening this morning! Via InvestorPlace Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment October 18, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session October 17, 2023 Via Benzinga Tiziana Life Sciences reveals "exciting" clinical data from latest MS trial October 17, 2023 --News Direct-- Via News Direct Tiziana Life Sciences reveals "exciting" clinical data from latest MS trial October 17, 2023 Tiziana Life Sciences Ltd (NASDAQ:TLSA) chief medical officer and chief operating officer Matthew Davis speaks to Thomas Warner from Proactive after the clinical-stage biopharmaceutical company... Via TheNewswire.com Tiziana Life Sciences reports six-month PET scan results for MS patients October 16, 2023 --News Direct-- Via News Direct Tiziana Life Sciences reports six-month PET scan results for MS patients October 16, 2023 Tiziana Life Sciences Ltd (NASDAQ:TLSA) chief medical officer and chief operating officer Matthew Davis speaks to Thomas Warner from Proactive after the clinical-stage biopharmaceutical company... Via TheNewswire.com Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab October 16, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana to Announce Six-Month Human Safety and Biomarker Data at the ECTRIMS Annual Congress, Following-Up from Positive Outcomes Data Presented in June October 13, 2023 --News Direct-- Via News Direct Exposures Product Safety Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS (na-SPMS) October 13, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June October 12, 2023 Tiziana (NASDAQ: TLSA) is following up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of the Europea Via Benzinga Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress October 11, 2023 From Tiziana Life Sciences Ltd. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.